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Several groups  have  recently reported the existence of a  population of human  T 
cells capable of proliferating in response to signals from autologous, non-T, mononu- 
clear  cells  (1-4).  As  the  stimulator  cells  have  not  been  purposely  modified,  this 
proliferation may represent recognition of unaltered self determinants. In this report, 
we have  investigated the specificity and  function of this autologous, reactive T  cell 
(ARC).1 The data indicate that the ARC is: (a) activated by products of genes closely 
linked to the HLA-DR  locus of the major histocompatibility complex (MHC), and (b) 
required  for  the synthesis of substantial  amounts  of Ig by autologous  B  cells. This 
suggests that the ARC is a  helper cell capable of recognizing self MHC  determinants. 
Materials  and  Methods 
Cell Populations  and Culture.  Whole peripheral blood mononuclear cells (PBMC), T-enriched 
populations  (92  +  4%  T,  3  :l:  1%  Ig-bearing, 4  +  2%  esterase-positive cells), populations 
enriched for B cells and monoeytes (referred to as "B cells"; 40  +  8% Ig-bearing, 40  +  10% 
esterase-positive, 10  +  3%  T), as well as T-cell populations differing in their density, were 
obtained as previously described (5, 6). 
Reactivity to autologous and allogeneic cells was determined by culturing (37°C; in 95% air, 
5% CO2)  100,000  T-enriched responder cells with 50,000 mitomycin-C-treated (mitomycin C, 
Sigma Chemical Co.,  St.  Louis, Mo.;  50  pg mitomycin C/10v cells) B  cells in  RPMI  1640 
(Grand  Island  Biological Co.,  Grand  Island,  N.  Y.)  containing  serum  autologous  to  the 
responding cell  (human  autologus  serum  [HAS])  (10% HAS,  heated  at  56°C  for  30  rain). 
Proliferation was assayed by determining the amount of tritiated thymidine (3H-TdR; 2 Ci/ 
mM, New England Nuclear, Boston, Mass.) that was incorporated into DNA during the final 
18  h  of a  6-d culture.  Results are expressed as stimulation index  (SI, counts  per minute of 
cultures containing responders and stimulators/counts per minute of responders tested alone 
plus counts per minute of stimulators incubated alone). 
To negatively select for ARC, 3  ×  106 T-enriched populations were cultured with 1.5  X  106 
mitomycin-C-treated, autologous B cells in  10% HAS. At 72 and again at 96 h of culture, 5- 
bromo-2-deoxyuridine (BUDR, Sigma Chemical Co.) was added in a final concentration of 3.3 
/~g/ml. 18 h after the final addition of BUDR, all cultures were exposed to cool white light at 
23°C  for  2  h,  and  the  recovered, washed  cells tested  for  (a)  their subsequent  proliferative 
response  to  autologous  or  allogeneic  stimulator  cells  and  (b)  their  ability to  regulate  Ig 
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FiG.  1.  Autologous reactivity and helper function of 
gradient-fractionated  T cells. T-enriched populations 
were fractionated on a five-step discontinuous density 
gradient. Cells from the indicated fractions were then 
tested for (A) their proliferative reactivity to autolo- 
gous B cells, with the results presented as arithmetic 
mean SI +  SE, and (B) their ability to modulate,  in 
a ratio of 1:1, the PWM-induced  Ig synthesis among 
autologous B cells with the results expressed as mean 
maximal  nanograms  of Ig synthesized/106  B cells. 
The mean amount of Ig synthesized by B cells tested 
alone was 2,500 ng/106 cells. The data represent that 
obtained in two (Ig synthesis) or four (ARC prolifer- 
ation) experiments. 
production among autologous cells. 
Ig synthesis occurring during a  7-d culture of cells with  two concentrations of pokeweed 
mitogen (PWM, Grand Island Biological Co., 6.25  and  1.56/~g/ml) was determined utilizing 
a competitive-binding radioimmunoassay~ as previously described (5). Results are expressed as 
maximal nanograms of Ig synthesized/10  cells, i.e., that which resulted from exposure to the 
optimal concentration of PWM. 
Results 
As an initial step to determine the function of the ARC, T-enriched fractions were 
sedimented on a  five-step discontinuous bovine serum albumin (BSA) gradient (10%/ 
23%/26%/29%/33%  BSA) and cells from various fractions compared for their prolif- 
erative reactivity to autologous stimulators as well as for their ability to modulate Ig 
synthesis by autologous B cells (Fig. 1; fractions 1 +  2,  10%/23%,  23%/26% interfaces 
were pooled as were fractions 4  +  5, 29%/33% interface, and pellet, in order to obtain 
sufficient numbers of cells). Substantial reactivity to autologous, stimulator cells (SI 
>  4) was noted among T  cells localizing to fractions  1  4-  2, or 3, but not among cells 
localizing to  fractions 4  +  5  (SI <  2).  Low-density fractions containing ARC  also 
augmented  Ig  production  by  autologous  B  cells  (2.6-  and  2.1-fold,  respectively), 
although  high-density cells lacking ARC  did  not  (Fig.  1 B).  In  data  not  shown,  it 
could  be  demonstrated  that  these  high-density  cells  suppressed  Ig  synthesis  by 
autologous whole PBMC  but  did not inhibit the ARC  reactivity among low-density 
fractions. 
To more directly demonstrate that the ARC  may function as a  helper rather than 
as a  suppressor cell, advantage was  taken  of the fact  that  proliferating cells can  be 
suicided with  BUDR  and  light  (7).  The  utility of this  as  a  method  for selectively 
depleting ARC is indicated by data in Table I. T  cells were cultured with autologous 
B  cells, and  one-half of the  cultures  received  BUDR.  The  washed,  recovered  cells 
were  then  tested  at  equivalent  concentrations  of viable  cells  for  their  subsequent P.  HAUSMAN AND J.  STOBO  BRIEF  DEFINITIVE REPORT 
TASLZ I 
Negative Selection of ARC 
1539 
Populations used for neg-  Stimulator cells 
ative selection 
Individuals 
A  B  C 
HLA-A  W24 W32  W24  2  W33 W29 
HLA-B  7  14  7  5  49  37 
HLA-DR  6  --  6  7 
A  +  Am -  BUDR  4.2  41.9  65.9 
A  +  Am +  BUDR  1.4  44.4  60.6 
T  cells from individual A were cultured with mitomycin-(2-treated (m) autologous B cells in the 
absence (-) or presence (+) of BUDR. All cultures were exposed to light. The washed, recovered 
cells  were then  resuspended to comparable concentrations of viable cells  and  tested  for their 
subsequent proliferative response to either autologons B cells or B cells from two other individuals 
(B, (2). The HI,A-A, B, and DR phenotypes of the cells are indicated. Reactivity was measured by 
the incorporation of aH-TdR into DNA and is expressed  as the SI. The results  are representative 
of three  experiments.  Tissue  typing  was  performed utilizing  antisera  directed  against  eight 
different DR determinants (DR-I-DR-8). (--)  refers  to a  lack of reactivity with any of these 
antisera. 
reactivity to stimulator cells bearing known HLA-A, B, or DR phenotypes. Popula- 
tions which had been negatively selected for proliferating ARC (A  +  Am  +  BUDR, 
Table I)  demonstrated a  67% decrease in their subsequent  reactivity to autologous 
stimulators  (individual A, Table I)  but no decrease in their response to stimulators 
sharing a single HLA-A and B, but not a  definable DR, determinant  (individual B, 
Table I). In contrast, the subsequent  reactivity of the ARC-depleted population to 
stimulators disparate with regard to HLA-A and B determinants, but which did share 
one  DR  determinant  (individual  C,  Table  I),  was  decreased  by  8%.  These  data 
indicate  that  suicide  with  BUDR  and  light  does  provide  a  method  for  selective 
deletion of ARC.  Furthermore, they suggest  that  the ARC  is responsive to signals 
coded for by genes more closely linked to the HLA-DR, than  to the HLA-A, or B, 
locus. 
Populations  containing or negatively selected  for ARC  were  next compared,  in 
three ratios, for their modulating effect on the PWM-induced Ig synthesis by either 
autologous B cells or whole PBMC (Fig. 2). ARC-containing cells (T +  B -  BUDR) 
substantially  augmented  Ig  production by  autologous  B  cells  at  each  ratio  tested 
(11-, 24-,  and  8.4-fold increases in  Ig synthesis at  9/1,  3/1,  and  1/1  ratio of T/B, 
respectively,  Fig.  2A).  In  contrast,  populations  depleted  of ARC  demonstrated 
diminished helper activity. 
Three points concerning the relative loss of help among the ARC-depleted popu- 
lation  deserve emphasis.  First,  it  did  not  simply  reflect  inhibition  of Ig  synthesis 
caused by "carry over" of BUDR. T  cells that went through the negative selection 
procedure (T  +  B  +  BUDR) but that were not exposed to light did not inhibit Ig 
synthesis (13,000 ng of Ig/106 B cells) compared to controls (T +  B -  BUDR,  10,500 
ng of Ig/106 B  cells) when each regulatory population was tested at a  ratio of 3/1 
with autologous B cells, data not shown.  Second, the greater Ig synthesis noted by 
mixtures of B  cells  and  control T  cells  (T  +  B  --  BUDR)  was  not  related  to  Ig 
production  by  the  "carried over," stimulator  B  cells.  Maximal  PWM-induced  Ig 
synthesis by the control population tested alone was meager (13% of that noted when 
they were mixed at a  3/1 ratio with fresh B cells; mean of five experiments). Third, 
the apparent absence of help among the ARC-depleted population did not represent 1540  P.  HAUSMAN AND J.  STOBO  BRIEF  DEFINITIVE  REPORT 
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Fro.  2.  Regulatory  effect  of ARC  on  Ig  synthesis.  Control  populations  (0)  and  populations 
negatively  selected  for  proliferating  ARC  (O)  were  mixed  in  the  indicated  final  ratios  with 
autologous B cells (A) or whole PBMC (B).  100,000 cells from each mixture were then assayed for 
PWM-induced Ig synthesis. Results are presented as maximal nanograms of Ig synthesized per 106 
B cells (A) or per 10  e PBMC (B) and are representative of three experiments. (-) on the ordinate 
indicates the mean amount of lg synthesized by B cells or PBMC alone. 
the generation of suppressive influences. The negatively selected population contained 
less help than control T  cells and did not suppress Ig synthesis by whole, autologous 
PBMC (Fig. 2 B). 
Discussion 
Several  reports  have  now  confirmed  the  existence  of a  population  of human 
peripheral blood T cells capable of proliferating in response to signals from autologous 
B  cells  and  monocytes  (1-4).  Although  there  has  been  no  direct  data,  several 
observations have indirectly indicated that this ARC functions to regulate immuno- 
logic reactivity. On the one hand, the findings that ARC reactivity is decreased in 
patients  with  systemic  lupus  erythematosus  (3,  4,  8),  a  disorder  presumed  to  be 
accompanied  by  a  deficiency of immunosuppressive  influences;  and  is  increased 
among umbilical cord blood lymphocytes (9), a  mononuclear cell population mani- 
festing increased T-dependent immunosuppression (10); suggest that it functions as a 
suppressor cell. On the other hand, there exist observations to suggest that the ARC 
may  augment  immune  reactivity.  Vande  Stouwe  et  al.  (11) demonstrated  that 
activation of the ARC could help in the generation of alloreactive, cytotoxic T  cells. 
Moreover, two laboratories have reported diminished ARC reactivity in patients with 
chronic lymphocytic leukemia (8,  12), a disorder in which there may be a deficiency 
of helper T  cells (13).  The studies presented in this report substantiate the concept 
that  the ARC  is involved in  immunoregulation and support  its putative role as a 
helper cell. 
Crucial  to  the  conclusion  that  the  ARC  provides  help  for  Ig  synthesis are  the 
negative selection experiments outlined in Fig. 2. As net regulation presumably reflects 
a  balance between help and suppression, it might be expected that this helper-cell 
depleted population should suppress Ig synthesis. This did not occur (Fig.  2 B)  and P.  HAUSMAN AND J.  STOBO  BRIEF  DEFINITIVE REPORT  1541 
may be related to either the finding that negatively selected populations manifest a 
small degree of residual, autologous reactivity (Table I), or to the possibility that the 
ARC represents only one of two cooperating T  cells required to provide B-cell help 
(14-17). 
Previously, we reported that the ARC could be activated by autologous as well as 
allogeneic cells (18). This contrasts with data presented here (Table I). However, the 
previously published data utilized fetal calf serum in the culture medium, while the 
present studies utilized serum autologous to the responder cell. In data derived from 
experiments not presented here, it is clear that ARC specificity is crucially dependent 
on the source of the serum used in the culture medium and that at least a portion of 
the  reactivity generated  in  fetal  calf serum  is  dependent  on  interactions  between 
serum  constituents  and  cell-surface determinants  which  are  not  HLA  restricted,  e 
Although  somewhat  incomplete with  regard  to  DR  typing,  the  data  presented  in 
Table I  suggest  that  the activation of the ARC  is dependent  on products of genes 
more closely linked to the HLA-DR than to the HLA-A, or B, locus. If this is indeed 
the case, one might argue that the subsequent response of ARC-depleted populations 
to stimulators sharing one DR determinant would theoretically be reduced by 50%, 
rather than by 8%, as demonstrated in Table I. However, one could also argue that 
depletion of T  cells responsive to a  given DR determinant could result in a  relative 
enrichment for T  cells responsive to products of other DR loci. Indeed, after depletion 
of the ARC, the subsequent reactivity of the remaining cells to stimulators not sharing 
a definable DR determinant was increased 1.1-fold (reactivity to individual B, Table 
I).  The  finding  that  the  subsequent  reactivity  of ARC-negative  populations  to 
stimulator cells sharing a DR determinant was decreased and not increased, coupled 
with our findings that the data presented in Table I is reproducible, strongly suggest 
that signals activating the ARC  are more closely linked to the HLA-DR than to the 
HLA-A and B loci. Whether the specificity of the ARC  reactivity depicted in HAS 
truly represents a response to unaltered, self-MHC-determinants, to self-MHC-deter- 
minants seen in conjunction with another, unidentified antigen, or to MHC deter- 
minants modified either in vivo or in vitro, remains to be determined. 
Summary 
Normal  human  peripheral  blood  contains  a  population  of T  cells  (autologous 
reactive cells [ARC]) capable of proliferating in response to signals from autologous 
B cells and monocytes. Selective suicide of proliferating ARC with 5-bromo-2-deox- 
yuridine and light demonstrated that this ARC was responsive to signals coded for by 
genes more closely linked to the HLA-DR, than to the HLA-A, or HLA-B, loci. Density- 
gradient fractionation ofT cells indicated that populations enriched in ARC reactivity 
were also enriched for helper influences required  for Ig synthesis by autologous B 
cells. In contrast, populations negatively selected for proliferating ARC were deficient 
in helper activity. These studies indicate that the ARC is responsive, at least in part, 
to products of genes closely linked to the HLA-DR locus and can function as a helper 
cell. 
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